APO Research

APO RESEARCH · REPORT

Medical Second Opinion

Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.

Product & engineering

Understand the product.

Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.

Selected research

Industry Growth & Trends

Global Medical Second Opinion Industry Growth and Trends Forecast to 2032

Market perspective

Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.

According to APO Research, the global Medical Second Opinion market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Medical Second Opinion market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Medical Second Opinion market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medical Second Opinion market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medical Second Opinion.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Medical Second Opinion market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Medical Second Opinion Market by Company

HCA Hospitals

AXA PPP Healthcare

Royal London Group

Helsana Group

Cleveland Clinic

Amradnet

Best Doctors Inc

Inova Care

Toranomon Hospital

Keio University Hospital

Johns Hopkins Medicine

Penn Medicine

Oncology International Pvt. Ltd.

GrandOpinion

London Pain Clinic

Mondial Assistance

Medisense

Medo Asia Sdn. Bhd.

Medical Second Opinion Segment by Type

Hospitals

Medical Second Opinion Providing Companies

Health Insurance Companies

Medical Second Opinion Segment by Application

Cancer

Diabetes

Cardiac Disorders

Neurological Disorders

Ocular Disorders

Others

Medical Second Opinion Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Second Opinion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Second Opinion and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Second Opinion.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Medical Second Opinion companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Medical Second Opinion Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Medical Second Opinion Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Medical Second Opinion Market Share by Region (2021-2026) Table 4. Global Medical Second Opinion Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Medical Second Opinion Market Share by Region (2027-2032) Table 6. Global Medical Second Opinion Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Medical Second Opinion Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Medical Second Opinion Market Size Share by Type (2021-2026) Table 9. Global Medical Second Opinion Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Medical Second Opinion Market Size Share Forecasted by Type (2027-2032) Table 11. North America Medical Second Opinion Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Medical Second Opinion Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Medical Second Opinion Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Medical Second Opinion Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Medical Second Opinion Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Medical Second Opinion Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Medical Second Opinion Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Medical Second Opinion Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Medical Second Opinion Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Medical Second Opinion Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Medical Second Opinion Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Medical Second Opinion Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Medical Second Opinion Market Size Share by Application (2021-2026) Table 24. Global Medical Second Opinion Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Medical Second Opinion Market Size Share Forecasted by Application (2027-2032) Table 26. North America Medical Second Opinion Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Medical Second Opinion Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Medical Second Opinion Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Medical Second Opinion Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Medical Second Opinion Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Medical Second Opinion Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Medical Second Opinion Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Medical Second Opinion Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Medical Second Opinion Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Medical Second Opinion Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Medical Second Opinion Industry Trends Table 37. Medical Second Opinion Industry Drivers Table 38. Medical Second Opinion Industry Opportunities and Challenges Table 39. Medical Second Opinion Industry Restraints Table 40. Global Medical Second Opinion Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Medical Second Opinion Revenue Market Share by Company (2021-2026) Table 42. Global Medical Second Opinion Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Medical Second Opinion Key Company Headquarters & Area Served Table 44. Global Medical Second Opinion Company, Product Type & Application Table 45. Global Medical Second Opinion Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Medical Second Opinion by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. HCA Hospitals Company Information Table 49. HCA Hospitals Business Overview Table 50. HCA Hospitals Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. HCA Hospitals Medical Second Opinion Product Portfolio Table 52. HCA Hospitals Recent Development Table 53. AXA PPP Healthcare Company Information Table 54. AXA PPP Healthcare Business Overview Table 55. AXA PPP Healthcare Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. AXA PPP Healthcare Medical Second Opinion Product Portfolio Table 57. AXA PPP Healthcare Recent Development Table 58. Royal London Group Company Information Table 59. Royal London Group Business Overview Table 60. Royal London Group Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Royal London Group Medical Second Opinion Product Portfolio Table 62. Royal London Group Recent Development Table 63. Helsana Group Company Information Table 64. Helsana Group Business Overview Table 65. Helsana Group Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Helsana Group Medical Second Opinion Product Portfolio Table 67. Helsana Group Recent Development Table 68. Cleveland Clinic Company Information Table 69. Cleveland Clinic Business Overview Table 70. Cleveland Clinic Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Cleveland Clinic Medical Second Opinion Product Portfolio Table 72. Cleveland Clinic Recent Development Table 73. Amradnet Company Information Table 74. Amradnet Business Overview Table 75. Amradnet Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Amradnet Medical Second Opinion Product Portfolio Table 77. Amradnet Recent Development Table 78. Best Doctors Inc Company Information Table 79. Best Doctors Inc Business Overview Table 80. Best Doctors Inc Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Best Doctors Inc Medical Second Opinion Product Portfolio Table 82. Best Doctors Inc Recent Development Table 83. Inova Care Company Information Table 84. Inova Care Business Overview Table 85. Inova Care Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Inova Care Medical Second Opinion Product Portfolio Table 87. Inova Care Recent Development Table 88. Toranomon Hospital Company Information Table 89. Toranomon Hospital Business Overview Table 90. Toranomon Hospital Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Toranomon Hospital Medical Second Opinion Product Portfolio Table 92. Toranomon Hospital Recent Development Table 93. Keio University Hospital Company Information Table 94. Keio University Hospital Business Overview Table 95. Keio University Hospital Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Keio University Hospital Medical Second Opinion Product Portfolio Table 97. Keio University Hospital Recent Development Table 98. Johns Hopkins Medicine Company Information Table 99. Johns Hopkins Medicine Business Overview Table 100. Johns Hopkins Medicine Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Johns Hopkins Medicine Medical Second Opinion Product Portfolio Table 102. Johns Hopkins Medicine Recent Development Table 103. Penn Medicine Company Information Table 104. Penn Medicine Business Overview Table 105. Penn Medicine Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Penn Medicine Medical Second Opinion Product Portfolio Table 107. Penn Medicine Recent Development Table 108. Oncology International Pvt. Ltd. Company Information Table 109. Oncology International Pvt. Ltd. Business Overview Table 110. Oncology International Pvt. Ltd. Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Oncology International Pvt. Ltd. Medical Second Opinion Product Portfolio Table 112. Oncology International Pvt. Ltd. Recent Development Table 113. GrandOpinion Company Information Table 114. GrandOpinion Business Overview Table 115. GrandOpinion Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. GrandOpinion Medical Second Opinion Product Portfolio Table 117. GrandOpinion Recent Development Table 118. London Pain Clinic Company Information Table 119. London Pain Clinic Business Overview Table 120. London Pain Clinic Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. London Pain Clinic Medical Second Opinion Product Portfolio Table 122. London Pain Clinic Recent Development Table 123. Mondial Assistance Company Information Table 124. Mondial Assistance Business Overview Table 125. Mondial Assistance Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Mondial Assistance Medical Second Opinion Product Portfolio Table 127. Mondial Assistance Recent Development Table 128. Medisense Company Information Table 129. Medisense Business Overview Table 130. Medisense Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Medisense Medical Second Opinion Product Portfolio Table 132. Medisense Recent Development Table 133. Medo Asia Sdn. Bhd. Company Information Table 134. Medo Asia Sdn. Bhd. Business Overview Table 135. Medo Asia Sdn. Bhd. Medical Second Opinion Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Medo Asia Sdn. Bhd. Medical Second Opinion Product Portfolio Table 137. Medo Asia Sdn. Bhd. Recent Development Table 138. North America Medical Second Opinion Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Medical Second Opinion Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Medical Second Opinion Market Share by Country (2021-2026) Table 141. North America Medical Second Opinion Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Medical Second Opinion Market Share Forecast by Country (2027-2032) Table 143. Europe Medical Second Opinion Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Medical Second Opinion Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Medical Second Opinion Market Share by Country (2021-2026) Table 146. Europe Medical Second Opinion Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Medical Second Opinion Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Medical Second Opinion Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Medical Second Opinion Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Medical Second Opinion Market Share by Country (2021-2026) Table 151. Asia-Pacific Medical Second Opinion Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Medical Second Opinion Market Share Forecast by Country (2027-2032) Table 153. Latin America Medical Second Opinion Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Medical Second Opinion Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Medical Second Opinion Market Share by Country (2021-2026) Table 156. Latin America Medical Second Opinion Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Medical Second Opinion Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Medical Second Opinion Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Medical Second Opinion Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Medical Second Opinion Market Share by Country (2021-2026) Table 161. Middle East & Africa Medical Second Opinion Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Medical Second Opinion Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Medical Second Opinion Product Image Figure 3. Global Medical Second Opinion Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Medical Second Opinion Market Size (2021-2032) & (US$ Million) Figure 5. Global Medical Second Opinion Market Share by Region: 2025 VS 2032 Figure 6. Global Medical Second Opinion Market Share by Region (2021-2032) Figure 7. North America Medical Second Opinion Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Medical Second Opinion Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Medical Second Opinion Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Medical Second Opinion Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Medical Second Opinion Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Hospitals Image Figure 13. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Medical Second Opinion Providing Companies Image Figure 15. Global Medical Second Opinion Providing Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Health Insurance Companies Image Figure 17. Global Health Insurance Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Medical Second Opinion Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Medical Second Opinion Market Share by Type 2025 VS 2032 Figure 20. North America Medical Second Opinion Market Size Share by Type (2021-2032) Figure 21. Europe Medical Second Opinion Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Medical Second Opinion Market Size Share by Type (2021-2032) Figure 23. Latin America Medical Second Opinion Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Medical Second Opinion Market Size Share by Type (2021-2032) Figure 25. Cancer Image Figure 26. Global Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Diabetes Image Figure 28. Global Diabetes Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Cardiac Disorders Image Figure 30. Global Cardiac Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Neurological Disorders Image Figure 32. Global Neurological Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Ocular Disorders Image Figure 34. Global Ocular Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Others Image Figure 36. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Medical Second Opinion Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Medical Second Opinion Market Share by Application 2025 VS 2032 Figure 39. North America Medical Second Opinion Market Size Share by Application (2021-2032) Figure 40. Europe Medical Second Opinion Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Medical Second Opinion Market Size Share by Application (2021-2032) Figure 42. Latin America Medical Second Opinion Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Medical Second Opinion Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Medical Second Opinion Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Medical Second Opinion Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Medical Second Opinion Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Medical Second Opinion Market Share by Country (2021-2032) Figure 49. Europe Medical Second Opinion Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Medical Second Opinion Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Medical Second Opinion Market Share by Country (2021-2032) Figure 52. Asia-Pacific Medical Second Opinion Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Medical Second Opinion Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Medical Second Opinion Market Share by Country (2021-2032) Figure 55. Latin America Medical Second Opinion Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Medical Second Opinion Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Medical Second Opinion Market Share by Country (2021-2032) Figure 58. Middle East & Africa Medical Second Opinion Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Medical Second Opinion Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Medical Second Opinion Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • Hospitals
  • Medical Second Opinion Providing Companies
  • Health Insurance Companies
Applications
  • Cancer
  • Diabetes
  • Cardiac Disorders
  • Neurological Disorders
  • Ocular Disorders
  • Others
Companies covered
  • HCA Hospitals
  • AXA PPP Healthcare
  • Royal London Group
  • Helsana Group
  • Cleveland Clinic
  • Amradnet
  • Best Doctors Inc
  • Inova Care
  • Toranomon Hospital
  • Keio University Hospital
  • Johns Hopkins Medicine
  • Penn Medicine
  • Oncology International Pvt. Ltd.
  • GrandOpinion
  • London Pain Clinic
  • Mondial Assistance
  • Medisense
  • Medo Asia Sdn. Bhd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Medical Second Opinion Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Medical Second Opinion Market Size by Region (2021-2032)
  5. 1.4.1 Global Medical Second Opinion Market Size by Region (2021-2026)
  6. 1.4.2 Global Medical Second Opinion Market Size by Region (2027-2032)
  7. 1.5 Key Regions Medical Second Opinion Market Size (2021-2032)
  8. 1.5.1 North America Medical Second Opinion Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Medical Second Opinion Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Medical Second Opinion Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Medical Second Opinion Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Medical Second Opinion Market Size Growth Rate (2021-2032)
2 Medical Second Opinion Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Hospitals
  3. 2.1.2 Medical Second Opinion Providing Companies
  4. 2.1.3 Health Insurance Companies
  5. 2.2 Global Medical Second Opinion Market Size by Type
  6. 2.2.1 Global Medical Second Opinion Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Medical Second Opinion Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Medical Second Opinion Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Medical Second Opinion Market Size by Regions
  10. 2.3.1 North America Medical Second Opinion Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Medical Second Opinion Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Medical Second Opinion Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Medical Second Opinion Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Medical Second Opinion Market Size Breakdown by Type (2021-2026)
3 Medical Second Opinion Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Cancer
  3. 3.1.2 Diabetes
  4. 3.1.3 Cardiac Disorders
  5. 3.1.4 Neurological Disorders
  6. 3.1.5 Ocular Disorders
  7. 3.1.6 Others
  8. 3.2 Global Medical Second Opinion Market Size by Application
  9. 3.2.1 Global Medical Second Opinion Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global Medical Second Opinion Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global Medical Second Opinion Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global Medical Second Opinion Market Size by Regions
  13. 3.3.1 North America Medical Second Opinion Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe Medical Second Opinion Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific Medical Second Opinion Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America Medical Second Opinion Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa Medical Second Opinion Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Medical Second Opinion Industry Trends
  2. 4.2 Medical Second Opinion Industry Drivers
  3. 4.3 Medical Second Opinion Industry Opportunities and Challenges
  4. 4.4 Medical Second Opinion Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Medical Second Opinion Revenue (2021-2026)
  2. 5.2 Global Medical Second Opinion Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Medical Second Opinion Key Company Headquarters & Area Served
  4. 5.4 Global Medical Second Opinion Company, Product Type & Application
  5. 5.5 Global Medical Second Opinion Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Medical Second Opinion Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Medical Second Opinion Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Medical Second Opinion Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 HCA Hospitals
  2. 6.1.1 HCA Hospitals Company Information
  3. 6.1.2 HCA Hospitals Business Overview
  4. 6.1.3 HCA Hospitals Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 HCA Hospitals Medical Second Opinion Product Portfolio
  6. 6.1.5 HCA Hospitals Recent Developments
  7. 6.2 AXA PPP Healthcare
  8. 6.2.1 AXA PPP Healthcare Company Information
  9. 6.2.2 AXA PPP Healthcare Business Overview
  10. 6.2.3 AXA PPP Healthcare Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 AXA PPP Healthcare Medical Second Opinion Product Portfolio
  12. 6.2.5 AXA PPP Healthcare Recent Developments
  13. 6.3 Royal London Group
  14. 6.3.1 Royal London Group Company Information
  15. 6.3.2 Royal London Group Business Overview
  16. 6.3.3 Royal London Group Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Royal London Group Medical Second Opinion Product Portfolio
  18. 6.3.5 Royal London Group Recent Developments
  19. 6.4 Helsana Group
  20. 6.4.1 Helsana Group Company Information
  21. 6.4.2 Helsana Group Business Overview
  22. 6.4.3 Helsana Group Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Helsana Group Medical Second Opinion Product Portfolio
  24. 6.4.5 Helsana Group Recent Developments
  25. 6.5 Cleveland Clinic
  26. 6.5.1 Cleveland Clinic Company Information
  27. 6.5.2 Cleveland Clinic Business Overview
  28. 6.5.3 Cleveland Clinic Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Cleveland Clinic Medical Second Opinion Product Portfolio
  30. 6.5.5 Cleveland Clinic Recent Developments
  31. 6.6 Amradnet
  32. 6.6.1 Amradnet Company Information
  33. 6.6.2 Amradnet Business Overview
  34. 6.6.3 Amradnet Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Amradnet Medical Second Opinion Product Portfolio
  36. 6.6.5 Amradnet Recent Developments
  37. 6.7 Best Doctors Inc
  38. 6.7.1 Best Doctors Inc Company Information
  39. 6.7.2 Best Doctors Inc Business Overview
  40. 6.7.3 Best Doctors Inc Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Best Doctors Inc Medical Second Opinion Product Portfolio
  42. 6.7.5 Best Doctors Inc Recent Developments
  43. 6.8 Inova Care
  44. 6.8.1 Inova Care Company Information
  45. 6.8.2 Inova Care Business Overview
  46. 6.8.3 Inova Care Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Inova Care Medical Second Opinion Product Portfolio
  48. 6.8.5 Inova Care Recent Developments
  49. 6.9 Toranomon Hospital
  50. 6.9.1 Toranomon Hospital Company Information
  51. 6.9.2 Toranomon Hospital Business Overview
  52. 6.9.3 Toranomon Hospital Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Toranomon Hospital Medical Second Opinion Product Portfolio
  54. 6.9.5 Toranomon Hospital Recent Developments
  55. 6.10 Keio University Hospital
  56. 6.10.1 Keio University Hospital Company Information
  57. 6.10.2 Keio University Hospital Business Overview
  58. 6.10.3 Keio University Hospital Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Keio University Hospital Medical Second Opinion Product Portfolio
  60. 6.10.5 Keio University Hospital Recent Developments
  61. 6.11 Johns Hopkins Medicine
  62. 6.11.1 Johns Hopkins Medicine Company Information
  63. 6.11.2 Johns Hopkins Medicine Business Overview
  64. 6.11.3 Johns Hopkins Medicine Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Johns Hopkins Medicine Medical Second Opinion Product Portfolio
  66. 6.11.5 Johns Hopkins Medicine Recent Developments
  67. 6.12 Penn Medicine
  68. 6.12.1 Penn Medicine Company Information
  69. 6.12.2 Penn Medicine Business Overview
  70. 6.12.3 Penn Medicine Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Penn Medicine Medical Second Opinion Product Portfolio
  72. 6.12.5 Penn Medicine Recent Developments
  73. 6.13 Oncology International Pvt. Ltd.
  74. 6.13.1 Oncology International Pvt. Ltd. Company Information
  75. 6.13.2 Oncology International Pvt. Ltd. Business Overview
  76. 6.13.3 Oncology International Pvt. Ltd. Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Oncology International Pvt. Ltd. Medical Second Opinion Product Portfolio
  78. 6.13.5 Oncology International Pvt. Ltd. Recent Developments
  79. 6.14 GrandOpinion
  80. 6.14.1 GrandOpinion Company Information
  81. 6.14.2 GrandOpinion Business Overview
  82. 6.14.3 GrandOpinion Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 GrandOpinion Medical Second Opinion Product Portfolio
  84. 6.14.5 GrandOpinion Recent Developments
  85. 6.15 London Pain Clinic
  86. 6.15.1 London Pain Clinic Company Information
  87. 6.15.2 London Pain Clinic Business Overview
  88. 6.15.3 London Pain Clinic Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 London Pain Clinic Medical Second Opinion Product Portfolio
  90. 6.15.5 London Pain Clinic Recent Developments
  91. 6.16 Mondial Assistance
  92. 6.16.1 Mondial Assistance Company Information
  93. 6.16.2 Mondial Assistance Business Overview
  94. 6.16.3 Mondial Assistance Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Mondial Assistance Medical Second Opinion Product Portfolio
  96. 6.16.5 Mondial Assistance Recent Developments
  97. 6.17 Medisense
  98. 6.17.1 Medisense Company Information
  99. 6.17.2 Medisense Business Overview
  100. 6.17.3 Medisense Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Medisense Medical Second Opinion Product Portfolio
  102. 6.17.5 Medisense Recent Developments
  103. 6.18 Medo Asia Sdn. Bhd.
  104. 6.18.1 Medo Asia Sdn. Bhd. Company Information
  105. 6.18.2 Medo Asia Sdn. Bhd. Business Overview
  106. 6.18.3 Medo Asia Sdn. Bhd. Medical Second Opinion Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Medo Asia Sdn. Bhd. Medical Second Opinion Product Portfolio
  108. 6.18.5 Medo Asia Sdn. Bhd. Recent Developments
7 North America
  1. 7.1 North America Medical Second Opinion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Medical Second Opinion Market Size by Country (2021-2026)
  3. 7.3 North America Medical Second Opinion Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Medical Second Opinion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Medical Second Opinion Market Size by Country (2021-2026)
  3. 8.3 Europe Medical Second Opinion Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Medical Second Opinion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Medical Second Opinion Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Medical Second Opinion Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Medical Second Opinion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Medical Second Opinion Market Size by Country (2021-2026)
  3. 10.3 South America Medical Second Opinion Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Medical Second Opinion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Medical Second Opinion Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Medical Second Opinion Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research